Mesothelin-Expressing Tumors
Oncology·MeSH: Carcinoma, Ovarian Epithelial
1 drug in development·1 company·1 clinical trial
Drug Pipeline by Phase
Phase 1(1)
| Drug | Company |
|---|---|
| CT-95 | Context Therapeutics Inc. (CNTX) |
Frequently asked questions
How many drugs are in development for Mesothelin-Expressing Tumors?
BioSniper tracks 1 drug in development for Mesothelin-Expressing Tumors across 1 company.
How many clinical trials target Mesothelin-Expressing Tumors?
There are 1 clinical trial targeting Mesothelin-Expressing Tumors tracked by BioSniper.
Deep-dive into Mesothelin-Expressing Tumors
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis